The global market for Supplement CDMO was valued at US$ 12010 million in the year 2024 and is projected to reach a revised size of US$ 18660 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Supplement CDMO Market

Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.

North American market for Supplement CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Supplement CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Supplement CDMO in Solid Dosage Form is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Supplement CDMO include Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, AGC Biologics, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Supplement CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Supplement CDMO.

The Supplement CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Supplement CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Supplement CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Supplement CDMO Market Report

Report Metric	Details
Report Name	Supplement CDMO Market
Accounted market size in year	US$ 12010 million
Forecasted market size in 2031	US$ 18660 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	‌Small Molecule CDMO‌ ‌Large Molecule CDMO‌
Segment by Application	Solid Dosage Form Liquid Dosage Form Powder Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, AGC Biologics, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, CordenPharma, Pierre Fabre, NutraPak USA, American Health Formulations, Alora Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Supplement CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Supplement CDMO Market growing?

Ans: The Supplement CDMO Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Supplement CDMO Market size in 2031?

Ans: The Supplement CDMO Market size in 2031 will be US$ 18660 million.

Who are the main players in the Supplement CDMO Market report?

Ans: The main players in the Supplement CDMO Market are Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, AGC Biologics, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, CordenPharma, Pierre Fabre, NutraPak USA, American Health Formulations, Alora Pharmaceuticals

What are the Application segmentation covered in the Supplement CDMO Market report?

Ans: The Applications covered in the Supplement CDMO Market report are Solid Dosage Form, Liquid Dosage Form, Powder, Others

What are the Type segmentation covered in the Supplement CDMO Market report?

Ans: The Types covered in the Supplement CDMO Market report are ‌Small Molecule CDMO‌, ‌Large Molecule CDMO‌

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Supplement CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 ‌Small Molecule CDMO‌

1.2.3 ‌Large Molecule CDMO‌

1.3 Market by Application

1.3.1 Global Supplement CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Dosage Form

1.3.3 Liquid Dosage Form

1.3.4 Powder

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Supplement CDMO Market Perspective (2020-2031)

2.2 Global Supplement CDMO Growth Trends by Region

2.2.1 Global Supplement CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Supplement CDMO Historic Market Size by Region (2020-2025)

2.2.3 Supplement CDMO Forecasted Market Size by Region (2026-2031)

2.3 Supplement CDMO Market Dynamics

2.3.1 Supplement CDMO Industry Trends

2.3.2 Supplement CDMO Market Drivers

2.3.3 Supplement CDMO Market Challenges

2.3.4 Supplement CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Supplement CDMO Players by Revenue

3.1.1 Global Top Supplement CDMO Players by Revenue (2020-2025)

3.1.2 Global Supplement CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Top Supplement CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Supplement CDMO Revenue

3.4 Global Supplement CDMO Market Concentration Ratio

3.4.1 Global Supplement CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Supplement CDMO Revenue in 2024

3.5 Global Key Players of Supplement CDMO Head office and Area Served

3.6 Global Key Players of Supplement CDMO, Product and Application

3.7 Global Key Players of Supplement CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Supplement CDMO Breakdown Data by Type

4.1 Global Supplement CDMO Historic Market Size by Type (2020-2025)

4.2 Global Supplement CDMO Forecasted Market Size by Type (2026-2031)

5 Supplement CDMO Breakdown Data by Application

5.1 Global Supplement CDMO Historic Market Size by Application (2020-2025)

5.2 Global Supplement CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Supplement CDMO Market Size (2020-2031)

6.2 North America Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Supplement CDMO Market Size by Country (2020-2025)

6.4 North America Supplement CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Supplement CDMO Market Size (2020-2031)

7.2 Europe Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Supplement CDMO Market Size by Country (2020-2025)

7.4 Europe Supplement CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Supplement CDMO Market Size (2020-2031)

8.2 Asia-Pacific Supplement CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Supplement CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Supplement CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Supplement CDMO Market Size (2020-2031)

9.2 Latin America Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Supplement CDMO Market Size by Country (2020-2025)

9.4 Latin America Supplement CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Supplement CDMO Market Size (2020-2031)

10.2 Middle East & Africa Supplement CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Supplement CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Supplement CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biofarma Group

11.1.1 Biofarma Group Company Details

11.1.2 Biofarma Group Business Overview

11.1.3 Biofarma Group Supplement CDMO Introduction

11.1.4 Biofarma Group Revenue in Supplement CDMO Business (2020-2025)

11.1.5 Biofarma Group Recent Development

11.2 SFI Health Solutions

11.2.1 SFI Health Solutions Company Details

11.2.2 SFI Health Solutions Business Overview

11.2.3 SFI Health Solutions Supplement CDMO Introduction

11.2.4 SFI Health Solutions Revenue in Supplement CDMO Business (2020-2025)

11.2.5 SFI Health Solutions Recent Development

11.3 TCI Bio

11.3.1 TCI Bio Company Details

11.3.2 TCI Bio Business Overview

11.3.3 TCI Bio Supplement CDMO Introduction

11.3.4 TCI Bio Revenue in Supplement CDMO Business (2020-2025)

11.3.5 TCI Bio Recent Development

11.4 Lonza

11.4.1 Lonza Company Details

11.4.2 Lonza Business Overview

11.4.3 Lonza Supplement CDMO Introduction

11.4.4 Lonza Revenue in Supplement CDMO Business (2020-2025)

11.4.5 Lonza Recent Development

11.5 HERMES PHARMA

11.5.1 HERMES PHARMA Company Details

11.5.2 HERMES PHARMA Business Overview

11.5.3 HERMES PHARMA Supplement CDMO Introduction

11.5.4 HERMES PHARMA Revenue in Supplement CDMO Business (2020-2025)

11.5.5 HERMES PHARMA Recent Development

11.6 AGC Biologics

11.6.1 AGC Biologics Company Details

11.6.2 AGC Biologics Business Overview

11.6.3 AGC Biologics Supplement CDMO Introduction

11.6.4 AGC Biologics Revenue in Supplement CDMO Business (2020-2025)

11.6.5 AGC Biologics Recent Development

11.7 Vitaquest

11.7.1 Vitaquest Company Details

11.7.2 Vitaquest Business Overview

11.7.3 Vitaquest Supplement CDMO Introduction

11.7.4 Vitaquest Revenue in Supplement CDMO Business (2020-2025)

11.7.5 Vitaquest Recent Development

11.8 Catalent

11.8.1 Catalent Company Details

11.8.2 Catalent Business Overview

11.8.3 Catalent Supplement CDMO Introduction

11.8.4 Catalent Revenue in Supplement CDMO Business (2020-2025)

11.8.5 Catalent Recent Development

11.9 KD Pharma Group

11.9.1 KD Pharma Group Company Details

11.9.2 KD Pharma Group Business Overview

11.9.3 KD Pharma Group Supplement CDMO Introduction

11.9.4 KD Pharma Group Revenue in Supplement CDMO Business (2020-2025)

11.9.5 KD Pharma Group Recent Development

11.10 Pharma Tech Industries

11.10.1 Pharma Tech Industries Company Details

11.10.2 Pharma Tech Industries Business Overview

11.10.3 Pharma Tech Industries Supplement CDMO Introduction

11.10.4 Pharma Tech Industries Revenue in Supplement CDMO Business (2020-2025)

11.10.5 Pharma Tech Industries Recent Development

11.11 CordenPharma

11.11.1 CordenPharma Company Details

11.11.2 CordenPharma Business Overview

11.11.3 CordenPharma Supplement CDMO Introduction

11.11.4 CordenPharma Revenue in Supplement CDMO Business (2020-2025)

11.11.5 CordenPharma Recent Development

11.12 Pierre Fabre

11.12.1 Pierre Fabre Company Details

11.12.2 Pierre Fabre Business Overview

11.12.3 Pierre Fabre Supplement CDMO Introduction

11.12.4 Pierre Fabre Revenue in Supplement CDMO Business (2020-2025)

11.12.5 Pierre Fabre Recent Development

11.13 NutraPak USA

11.13.1 NutraPak USA Company Details

11.13.2 NutraPak USA Business Overview

11.13.3 NutraPak USA Supplement CDMO Introduction

11.13.4 NutraPak USA Revenue in Supplement CDMO Business (2020-2025)

11.13.5 NutraPak USA Recent Development

11.14 American Health Formulations

11.14.1 American Health Formulations Company Details

11.14.2 American Health Formulations Business Overview

11.14.3 American Health Formulations Supplement CDMO Introduction

11.14.4 American Health Formulations Revenue in Supplement CDMO Business (2020-2025)

11.14.5 American Health Formulations Recent Development

11.15 Alora Pharmaceuticals

11.15.1 Alora Pharmaceuticals Company Details

11.15.2 Alora Pharmaceuticals Business Overview

11.15.3 Alora Pharmaceuticals Supplement CDMO Introduction

11.15.4 Alora Pharmaceuticals Revenue in Supplement CDMO Business (2020-2025)

11.15.5 Alora Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pharma Tech Industries

American Health Formulations

Alora Pharmaceuticals

List of Tables

Table 1. Global Supplement CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of ‌Small Molecule CDMO‌

Table 3. Key Players of ‌Large Molecule CDMO‌

Table 4. Global Supplement CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Supplement CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Supplement CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Supplement CDMO Market Share by Region (2020-2025)

Table 8. Global Supplement CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Supplement CDMO Market Share by Region (2026-2031)

Table 10. Supplement CDMO Market Trends

Table 11. Supplement CDMO Market Drivers

Table 12. Supplement CDMO Market Challenges

Table 13. Supplement CDMO Market Restraints

Table 14. Global Supplement CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Supplement CDMO Market Share by Players (2020-2025)

Table 16. Global Top Supplement CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Supplement CDMO as of 2024)

Table 17. Ranking of Global Top Supplement CDMO Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Supplement CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Supplement CDMO, Headquarters and Area Served

Table 20. Global Key Players of Supplement CDMO, Product and Application

Table 21. Global Key Players of Supplement CDMO, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Supplement CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Supplement CDMO Revenue Market Share by Type (2020-2025)

Table 25. Global Supplement CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Supplement CDMO Revenue Market Share by Type (2026-2031)

Table 27. Global Supplement CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Supplement CDMO Revenue Market Share by Application (2020-2025)

Table 29. Global Supplement CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Supplement CDMO Revenue Market Share by Application (2026-2031)

Table 31. North America Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Supplement CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Supplement CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Supplement CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Supplement CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Supplement CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Supplement CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 46. Biofarma Group Company Details

Table 47. Biofarma Group Business Overview

Table 48. Biofarma Group Supplement CDMO Product

Table 49. Biofarma Group Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 50. Biofarma Group Recent Development

Table 51. SFI Health Solutions Company Details

Table 52. SFI Health Solutions Business Overview

Table 53. SFI Health Solutions Supplement CDMO Product

Table 54. SFI Health Solutions Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 55. SFI Health Solutions Recent Development

Table 56. TCI Bio Company Details

Table 57. TCI Bio Business Overview

Table 58. TCI Bio Supplement CDMO Product

Table 59. TCI Bio Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 60. TCI Bio Recent Development

Table 61. Lonza Company Details

Table 62. Lonza Business Overview

Table 63. Lonza Supplement CDMO Product

Table 64. Lonza Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 65. Lonza Recent Development

Table 66. HERMES PHARMA Company Details

Table 67. HERMES PHARMA Business Overview

Table 68. HERMES PHARMA Supplement CDMO Product

Table 69. HERMES PHARMA Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 70. HERMES PHARMA Recent Development

Table 71. AGC Biologics Company Details

Table 72. AGC Biologics Business Overview

Table 73. AGC Biologics Supplement CDMO Product

Table 74. AGC Biologics Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 75. AGC Biologics Recent Development

Table 76. Vitaquest Company Details

Table 77. Vitaquest Business Overview

Table 78. Vitaquest Supplement CDMO Product

Table 79. Vitaquest Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 80. Vitaquest Recent Development

Table 81. Catalent Company Details

Table 82. Catalent Business Overview

Table 83. Catalent Supplement CDMO Product

Table 84. Catalent Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 85. Catalent Recent Development

Table 86. KD Pharma Group Company Details

Table 87. KD Pharma Group Business Overview

Table 88. KD Pharma Group Supplement CDMO Product

Table 89. KD Pharma Group Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 90. KD Pharma Group Recent Development

Table 91. Pharma Tech Industries Company Details

Table 92. Pharma Tech Industries Business Overview

Table 93. Pharma Tech Industries Supplement CDMO Product

Table 94. Pharma Tech Industries Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 95. Pharma Tech Industries Recent Development

Table 96. CordenPharma Company Details

Table 97. CordenPharma Business Overview

Table 98. CordenPharma Supplement CDMO Product

Table 99. CordenPharma Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 100. CordenPharma Recent Development

Table 101. Pierre Fabre Company Details

Table 102. Pierre Fabre Business Overview

Table 103. Pierre Fabre Supplement CDMO Product

Table 104. Pierre Fabre Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 105. Pierre Fabre Recent Development

Table 106. NutraPak USA Company Details

Table 107. NutraPak USA Business Overview

Table 108. NutraPak USA Supplement CDMO Product

Table 109. NutraPak USA Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 110. NutraPak USA Recent Development

Table 111. American Health Formulations Company Details

Table 112. American Health Formulations Business Overview

Table 113. American Health Formulations Supplement CDMO Product

Table 114. American Health Formulations Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 115. American Health Formulations Recent Development

Table 116. Alora Pharmaceuticals Company Details

Table 117. Alora Pharmaceuticals Business Overview

Table 118. Alora Pharmaceuticals Supplement CDMO Product

Table 119. Alora Pharmaceuticals Revenue in Supplement CDMO Business (2020-2025) & (US$ Million)

Table 120. Alora Pharmaceuticals Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Supplement CDMO Picture

Figure 2. Global Supplement CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Supplement CDMO Market Share by Type: 2024 VS 2031

Figure 4. ‌Small Molecule CDMO‌ Features

Figure 5. ‌Large Molecule CDMO‌ Features

Figure 6. Global Supplement CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Supplement CDMO Market Share by Application: 2024 VS 2031

Figure 8. Solid Dosage Form Case Studies

Figure 9. Liquid Dosage Form Case Studies

Figure 10. Powder Case Studies

Figure 11. Others Case Studies

Figure 12. Supplement CDMO Report Years Considered

Figure 13. Global Supplement CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Supplement CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Supplement CDMO Market Share by Region: 2024 VS 2031

Figure 16. Global Supplement CDMO Market Share by Players in 2024

Figure 17. Global Supplement CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Supplement CDMO Revenue in 2024

Figure 19. North America Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Supplement CDMO Market Share by Country (2020-2031)

Figure 21. United States Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Supplement CDMO Market Share by Country (2020-2031)

Figure 25. Germany Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Supplement CDMO Market Share by Region (2020-2031)

Figure 33. China Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Supplement CDMO Market Share by Country (2020-2031)

Figure 41. Mexico Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Supplement CDMO Market Share by Country (2020-2031)

Figure 45. Turkey Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Supplement CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Biofarma Group Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 49. SFI Health Solutions Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 50. TCI Bio Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 51. Lonza Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 52. HERMES PHARMA Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 53. AGC Biologics Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 54. Vitaquest Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 55. Catalent Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 56. KD Pharma Group Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 57. Pharma Tech Industries Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 58. CordenPharma Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 59. Pierre Fabre Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 60. NutraPak USA Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 61. American Health Formulations Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 62. Alora Pharmaceuticals Revenue Growth Rate in Supplement CDMO Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38U19850

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Z20517

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28R19905

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17G20275

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions